Edge Therapeutics Reports Third Quarter 2017 Financial Results
Nov 01, 2017 11:00 am UTC| Business
BERKELEY HEIGHTS, N.J., Nov. 01, 2017 -- Edge Therapeutics®, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life-threatening conditions,...
Tonix Pharmaceuticals to Present at 23rd Annual BIO-Europe International Partnering Conference
Nov 01, 2017 11:00 am UTC| Business
NEW YORK, Nov. 01, 2017 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company developing innovative pharmaceutical and biological products to address major public health challenges, announced today...
Nov 01, 2017 11:00 am UTC| Business
ORLANDO, Fla., Nov. 01, 2017 -- Meritage Homes Corporation (NYSE:MTH), a leading U.S. homebuilder, today announced that it has closed on the sale of 183 lots within the Doctor Phillips submarket of Orlando. The new...
The Hershey Company Debuts Its Fourth and Newest Flavor, HERSHEY’S GOLD
Nov 01, 2017 11:00 am UTC| Business
HERSHEY, Pa., Nov. 01, 2017 -- The Hershey Company (NYSE:HSY), the leading manufacturer in United States confection1, announces the official launch of Hershey’s Gold bars, the fourth flavor in the history of the iconic...
Agios Reports Third Quarter 2017 Financial Results
Nov 01, 2017 11:00 am UTC| Business
IDHIFA® Approval for IDH2m R/R AML Validates Precision Medicine Approach; Ivosidenib NDA Submission for IDH1m R/R AML on Track for Year End 2017 First Expansion Data from Ivosidenib Phase 1 Trial in IDH1m R/R AML and...
Nov 01, 2017 11:00 am UTC| Business
ROCKVILLE, Md., Nov. 01, 2017 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV®...
Curis to Release Third Quarter 2017 Financial Results and Hold Conference Call on November 7, 2017
Nov 01, 2017 11:00 am UTC| Business
LEXINGTON, Mass., Nov. 01, 2017 -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight